IRIS
MEDAGLINI, DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.549
EU - Europa 9.946
AS - Asia 5.467
SA - Sud America 995
Continente sconosciuto - Info sul continente non disponibili 334
AF - Africa 317
OC - Oceania 22
AN - Antartide 1
Totale 29.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.217
IT - Italia 2.033
RU - Federazione Russa 2.014
SG - Singapore 1.746
CN - Cina 1.708
GB - Regno Unito 1.546
IE - Irlanda 1.197
BR - Brasile 776
SE - Svezia 699
VN - Vietnam 595
DE - Germania 592
UA - Ucraina 522
FR - Francia 496
HK - Hong Kong 447
FI - Finlandia 411
KR - Corea 289
ZA - Sudafrica 181
CA - Canada 168
IN - India 163
BD - Bangladesh 127
ES - Italia 75
NL - Olanda 72
PL - Polonia 57
AR - Argentina 56
MX - Messico 51
TR - Turchia 45
JP - Giappone 41
IQ - Iraq 40
NG - Nigeria 40
UZ - Uzbekistan 38
EC - Ecuador 34
VE - Venezuela 34
BE - Belgio 33
AT - Austria 32
CO - Colombia 28
ID - Indonesia 27
PK - Pakistan 27
CR - Costa Rica 24
CH - Svizzera 22
CL - Cile 22
LT - Lituania 21
CZ - Repubblica Ceca 19
IL - Israele 19
AU - Australia 18
MY - Malesia 18
CI - Costa d'Avorio 17
JM - Giamaica 16
KE - Kenya 16
SA - Arabia Saudita 16
IR - Iran 14
EG - Egitto 13
GR - Grecia 13
MA - Marocco 13
PE - Perù 12
PH - Filippine 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
DK - Danimarca 11
HN - Honduras 11
BO - Bolivia 10
EE - Estonia 10
GT - Guatemala 10
PT - Portogallo 10
JO - Giordania 9
NP - Nepal 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
EU - Europa 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
CW - ???statistics.table.value.countryCode.CW??? 7
OM - Oman 7
SC - Seychelles 7
SI - Slovenia 7
TH - Thailandia 7
ET - Etiopia 6
RS - Serbia 6
SV - El Salvador 6
BB - Barbados 5
BG - Bulgaria 5
DZ - Algeria 5
GP - Guadalupe 5
KG - Kirghizistan 5
MD - Moldavia 5
NI - Nicaragua 5
NO - Norvegia 5
PA - Panama 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
KZ - Kazakistan 4
LB - Libano 4
LK - Sri Lanka 4
MT - Malta 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CG - Congo 3
GE - Georgia 3
Totale 29.253
Salva come PNG Salva come JPEG
Città #
Dallas 1.422
Ashburn 1.239
Southend 1.198
Dublin 1.193
Singapore 947
Fairfield 889
Chandler 678
San Jose 632
Santa Clara 608
Moscow 540
Milan 473
Hong Kong 420
Jacksonville 419
Beijing 402
Woodbridge 401
Siena 369
Houston 339
Hefei 335
Seattle 334
Council Bluffs 318
Wilmington 313
Cambridge 298
Seoul 280
Ann Arbor 246
Los Angeles 228
Helsinki 219
Princeton 199
Rome 187
New York 182
Munich 177
The Dalles 166
Johannesburg 161
Ho Chi Minh City 140
Hanoi 134
Nanjing 134
Lauterbourg 129
Florence 125
Dong Ket 121
Boardman 88
São Paulo 82
North Bergen 75
Lappeenranta 73
San Mateo 73
San Diego 70
Buffalo 65
Columbus 60
Shanghai 60
Lancaster 59
Orem 54
London 50
Phoenix 50
Chicago 49
Shenyang 49
Menlo Park 48
Montreal 47
Frankfurt am Main 46
Nuremberg 43
Toronto 43
Nanchang 41
Turku 40
Tokyo 39
Bengaluru 38
Redondo Beach 38
Abuja 37
Denver 36
Chennai 33
Washington 32
Brussels 31
Tashkent 31
Dearborn 30
Warsaw 30
Amsterdam 29
Brooklyn 28
San Francisco 28
Tianjin 28
Málaga 27
Figino 26
Atlanta 25
Düsseldorf 25
Kunming 25
Da Nang 24
Hebei 23
Turin 23
Belo Horizonte 22
Boston 22
Fremont 22
Guangzhou 22
Haiphong 22
Jiaxing 22
Poplar 20
Naples 19
Rio de Janeiro 19
Bologna 18
Brasília 18
Norwalk 18
Philadelphia 18
Salt Lake City 18
Abidjan 17
Miami 17
Changsha 16
Totale 18.876
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 378
13C-NMR determination of simultaneous xylose and glucose fermentation by a newly isolated strain (G11) of Klebsiella planticola 355
Vaginal immunization to elicit primary T-cell activation and dissemination 337
Vaccination in the elderly: The challenge of immune changes with aging 336
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 333
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 329
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response 328
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 324
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 322
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 312
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 311
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 307
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 300
Correlates of vaccine-induced protective immunity against Ebola virus disease 298
Ebola vaccine R&D: Filling the knowledge gaps 297
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 295
Adoptive transfer of transgenic T cells to study mucosal adjuvants 295
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 292
Role of the microbiota in the modulation of vaccine immune responses 280
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells 279
Identification of a branching process model for adaptive immune response 278
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 272
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols 269
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 265
Assessment of mucosal immunity to HIV-1 264
Big science for vaccine development 263
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 262
Modulation of Primary Immune Response by Different Vaccine Adjuvants 259
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 254
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 248
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 239
Biotechnological approaches to fight pathogens at mucosal sites 234
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 233
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 232
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 231
Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface 228
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts 227
The European research effort for HIV/AIDS, malaria and tuberculosis 225
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 223
ADITEC: joining forces for next-generation vaccines 222
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii 221
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 220
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 218
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 216
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 216
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 214
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 214
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 214
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis 214
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii 213
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 212
Recombinant Gram-positive bacteria as vehicles of vaccine antigens 211
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 211
Vaccine adjuvants: A priority for vaccine research 210
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 210
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 210
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 209
Primary T-cell response to mucosal vaccination 209
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 206
La diagnosi eziologica della polmonite comunitaria: possibile ruolo della Real-Time PCR in una coorte di pazienti adulti e pediatrici 205
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 203
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 202
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 201
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 200
O:2-CRM(197) Conjugates against Salmonella Paratyphi A 200
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 198
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 197
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii 197
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 197
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 195
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 194
Recombinant Streptococcus gordonii as a mucosal vaccine vector 193
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 192
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 192
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 192
Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium 191
Surface display of recombinant proteins on Bacillus subtilis spores 191
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 190
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines 189
Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against Salmonella typhimurium and Salmonella Enteritidis 188
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa 188
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 187
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 187
Innate immunity against HIV: a priority target for HIV prevention research 185
Gram-positive commensal bacteria for mucosal vaccine delivery 184
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii 184
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 184
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 184
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 182
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii 181
Vaginal immunization with recombinant gram-positive bacteria 180
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens 179
NMR Investigation of the Simultaneous Fermentation of Xylose and Glucose by a Selected Strain of Klebsiella Planticola (G11) 175
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 175
Expression of measles virus antigens in Streptococcus gordonii 174
The European effort towards the development of mucosal vaccines for poverty-related diseases 174
Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine 173
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 172
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 172
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 172
Totale 22.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.406
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022992 0 0 0 0 64 27 85 53 83 142 184 354
2022/20232.352 146 238 317 305 212 463 61 205 181 49 118 57
2023/20242.022 72 67 160 118 79 518 665 65 43 87 35 113
2024/20254.385 129 179 428 248 535 278 204 263 435 180 422 1.084
2025/202610.350 779 1.459 1.038 1.217 1.838 356 1.044 382 473 621 368 775
2026/20272.450 493 388 855 705 9 0 0 0 0 0 0 0
Totale 29.631